Johnson & Johnson Announces $20.4 Million Settlement Ahead of Opioid Trial

    Johnson & Johnson announced it has reached a $20.4 million settlement with two Ohio counties ahead of a huge federal trial to determine responsibility for the opioid crisis, The Washington Post reports.

    Under the terms of the settlement, Johnson & Johnson will pay the counties $10 million in cash. The company will also reimburse them for $5 million in legal fees and direct $5.4 million to nonprofits for opioid-related programs in the two counties.

    Six defendants are scheduled to stand trial in a lawsuit brought by more than 2,500 cities, counties and Native American tribes. They include the three largest drug distributors in the country; Walgreens; Teva Pharmaceuticals; and a small Ohio-based drug distributor.

    The cases have been consolidated before a federal judge in Cleveland. Jury selection is scheduled to start on October 16.

    opioid-heroin-rx

    Heroin & the Opioid Epidemic: From Understanding to Action

    Heroin and other opioids are ravaging communities across America. Heroin-related deaths increased by more than five times between 2010 and 2017, and drug deaths from fentanyl and other synthetic opioids are seeing a sharp rise as well.

    Take action against this epidemic now
    By Partnership Staff
    October 2019

    Published

    October 2019

    We use cookies to improve your experience and serve you relevant information. To learn more, read our privacy policy.